I am slightly surprised BP doesn’t add Tollovid to Paxlovid. That makes it patentable. And sounds like it would really kick the snot out of Covid. GC needs to get on the phone and work that angle. License it out for $100 million a year. At that price it should be hard to say no. And that is the money that fixes their balance sheet.